Haemophilia
Издатель: Wiley · ISSN 13518216 · 58 статей
- From Bleeding Control to Health: Implementing Multidimensional and Multidisciplinary Hemophilia Care Into the Era of Therapeutic Innovation
- Current State of Moderate Congenital Haemophilia A and the Need for Preventive Treatment
- Symptoms, Diagnosis, and Treatment for Women and Girls With Hemophilia: A Narrative Review
- Issue Information
- A Common Language for the Multidisciplinary Team: Point‐of‐Care Musculoskeletal Ultrasound in Modern Haemophilia Care
-
Radiosynoviorthesis and Its Effectiveness: Brazilian Experience in 1136 Joints of 572 Patients With Hemophilic Arthropathy
ABSTRACT Introduction Synovium plays a central role in the development of haemophilic arthropathy (HA). Minimally invasive treatments for haemophilic synovitis are better options than surgery and radiosynoviorthesis (RSO) is considered...
-
Diagnostic and Treatment Availability of von Willebrand Disease Within Europe: Insights From a European Association for Hemophilia and Allied Disorders (EAHAD) Survey
ABSTRACT Background Von Willebrand disease (VWD) is the most common inherited bleeding disorder, yet its diagnosis and management remain heterogeneous across Europe due to variable access to diagnosis and care. Aim To characterize...
-
Health‐related Quality of Life in Adults With Haemophilia: A Systematic Review and Meta‐analysis of EQ‐5D and SF‐6D Health‐state Utilities
Abstract Introduction Health‐state utilities (HSUs) summarise health‐related quality of life for economic evaluation. Estimates in haemophilia vary by population, treatment context, instrument, value set, and recruitment setting. Aim To...
-
Self‐Reported Cannabis Use, Pain and Mental Health in People With Inheritable Bleeding Disorders
ABSTRACT Introduction Medical cannabis use has increased in the United States for managing symptoms such as pain, anxiety, sleep disturbance, and mood disorders. Self‐report remains the primary method for documenting cannabis use....
-
Genital Involvement in Female Patients With Congenital Type 1 Plasminogen Deficiency: A Case Series and Updated Literature Review
Abstract Introduction Congenital type 1 plasminogen deficiency (PLGD1) is an ultra‐rare disorder characterized by the formation of fibrin‐rich pseudomembranes on mucosal surfaces across multiple organ systems. In affected females,...
-
Coagulation Testing Practices and Guideline Adherence in Hemophilia A: A Retrospective Quality Assessment of a Dutch Expertise Hemophilia Treatment Center
Abstract Background Coagulation testing in persons with hemophilia A (PwHA) is required for diagnosis, monitoring replacement therapy, assessment of adherence, and detection of inhibitors. However, data on testing practices are limited,...
- Thrombolysis and Carotid Stenting for Acute Ischemic Stroke in Severe Hemophilia A: A Case Report
- Bridging Pediatric and Adult Haematology Care: A Single Centre Experience in Management of VWD Teen Pregnancies
-
Shared Decision‐Making in Haemophilia Involves More Treatment Differentiators in 2026
ABSTRACT Introduction Shared decision‐making regarding treatment choice in haemophilia care has become increasingly more complex and essential due to the availability of several innovative therapeutics that are characterized by their...
-
Data Collection on Rare Coagulation Disorders: Focus on Patients with Coagulation Factor X Deficiency
ABSTRACT Background Inherited coagulation factor X (FX) deficiency is an ultra‐rare coagulation disorder (estimated prevalence ∼1:1,000,000), characterized by reduced FX activity (FX:C) and bleeding manifestations, ranging from mild to...
-
Radiosynoviorthesis in People With Haemophilia—Pain‐Related and Clinical Outcomes: A Prospective Controlled Cohort Study
ABSTRACT Introduction Radiosynoviorthesis (RSO) may alleviate pain and clinical symptoms in people with haemophilia (PwH), however, controlled longitudinal data on these outcomes remain limited. Aim To evaluate the effects of RSO on...
-
The Correction Factor for Monitoring Efanesoctocog Alfa Is Not Always 2.5
ABSTRACT Introduction Efanesoctocog alfa (Altuvoct) is a recombinant super‐extended half‐life factor (F)VIII concentrate licensed in the United Kingdom for patients with severe and moderate haemophilia A. Concentrate potency is assigned...
-
Real‐World Clinical Data and Thrombin Generation of Efanesoctocog Alfa Prophylaxis in Pediatric Patients With Haemophilia A
ABSTRACT Background Clinical trials have shown efficacy and safety of efanesoctocog alfa prophylaxis in children and adults, however, real‐world data on the efficacy and safety remains scarce. Objectives To report real‐world data on the...
- Generative AI and the Unprotected Layer of Haemophilia Registries
- When Bleeding Signals Therapeutic Success: Early Response and Maintenance Therapy With Plasma‐Derived Human Plasminogen Replacement in Two Patients With Type 1 Plasminogen Deficiency
-
Emicizumab Prophylaxis in Patients With Acquired Hemophilia A During Immunosuppressive Therapy: Real‐World Data From the Spanish Acquired Hemophilia Registry
Abstract Introduction Acquired hemophilia A (AHA) is a rare bleeding disorder in which immunosuppressive therapy (IST) and hemostatic management remain challenging, particularly in elderly patients. Evidence supporting emicizumab use in...
-
Sharps Disposal Practices and Associated Factors Among Adults With Hemophilia Receiving Home‐Based Treatment
ABSTRACT Background The increasing use of home‐based parenteral therapies has made the safe management of sharps waste a significant public health concern. Aim This study aimed to evaluate sharps use and disposal practices among...
- Gene Therapy for Haemophilia: A Lived Experience Model to Guide Psychosocial Support Across the Whole Haemophilia Community in the Era of Gene Therapy
- Ultrasound Versus Magnetic Resonance Imaging for Haemophilic Arthropathy: A Systematic Review With Meta‐Analysis of Diagnostic Accuracy Across Joint Pathologies
- Arthroplasty After Hemophilia Gene Therapy: Perioperative Implications and Clinical Experience
- Association of TNFAIP3 Polymorphisms With Bleeding Phenotypes and FVIII Inhibitor Development in Patients With Hemophilia A: A Case‐Control Study
- Socio‑Economic and Education Profile of Children With Haemophilia A Receiving Prophylaxis and Their Families: Results From a Brazilian Cohort
- 100 Years of von Willebrand Disease (VWD): Comparison of Historical and Contemporary von Willebrand Factor (VWF) Activity Assays in the Laboratory Identification of VWD